Plus Therapeutics Announces Patient-Focused Presentation Supporting Brain Tumor Awareness Month

NEXT STORY
Vyriad Inc. Announces Development of a New Antibody Test to Determine Protective Immunity From COVID-19
PREV STORY
Montreal Heart Institute Colcorona Study receives grant from the COVID-19 Therapeutics Accelerator via the Bill & Melinda Gates Foundation to investigate cheap, readily available drug
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Bavarian Nordic to Present at Needham & Company’s 17th Annual Healthcare Conference in New York City

COPENHAGEN, Denmark - March 27, 2018 - Bavarian Nordic A/S (OMX:  BAVA, OTC: BVNRY) ...

author_avatar
NASDAQ Market News

Global In Silico/Computer-Aided Drug Discovery Services Market: Focus on Large Molecules (2020-2030)

author_avatar
NASDAQ Market News

Zai Lab Limited Announces Presentations at May Investor Conferences

author_avatar
NASDAQ Market News